Noel J P, Bingman C A, Deng T L, Dupureur C M, Hamilton K J, Jiang R T, Kwak J G, Sekharudu C, Sundaralingam M, Tsai M D
Department of Chemistry, Ohio State University, Columbus 43210.
Biochemistry. 1991 Dec 24;30(51):11801-11. doi: 10.1021/bi00115a010.
Site-directed mutagenesis studies of bovine pancreatic phospholipase A2 (PLA2, overproduced in Escherichia coli) showed that replacement of surface residue Lys-56 by a neutral or hydrophobic amino acid residue resulted in an unexpected and significant change in the function of the enzyme. The kcat for phosphatidylcholine micelles increases 3-4-fold for K56M, K56I, and K56F and ca. 2-fold for K56N and K56T but does not change for K56R. These results suggest that the side chain of residue 56 has significant influence on the activity of PLA2. In order to probe the structural basis for the enhanced activity, the crystal structures of wild-type and K56M PLA2 were determined by X-ray crystallography to a resolution of 1.8 A. The results suggest that the mutation has not only perturbed the conformation of the side chain of Met-56 locally but also caused conformational changes in the neighboring loop (residues 60-70), resulting in the formation of a hydrophobic pocket by residues Met-56, Tyr-52, and Tyr-69. Docking of a phosphatidylcholine inhibitor analogue into the active site of K56M, according to the structure of the complex of cobra venom PLA2-phosphatidylethanolamine inhibitor analogue [White, S.P., Scott, D. L., Otwinowski, Z., Gleb, M. H., & Sigler, P. (1990) Science 250, 1560-1563], showed that the choline moiety [N(CH3)3]+ is readily accommodated into the newly formed hydrophobic pocket with a high degree of surface complementarity. This suggests a possible interaction between residue 56 and the head group of the phospholipid, explaining the enhanced activities observed when the positively charged Lys-56 is substituted by apolar residues, viz., K56M, K56I, and K56F. Further support for this interpretation comes from the 5-fold enhancement in kcat for the mutant K56E with a negatively charged side chain, where there would be an attractive electrostatic interaction between the side chain of Glu-56 and the positively charged choline moiety. Our results also refute a recent report [Tomasselli, A. G., Hui, J., Fisher, J., Zürcher-Neely, H., Reardon, I.M., Oriaku, E., Kézdy, F.J., & Heinrikson, R.L. (1989) J. Biol. Chem. 264, 10041-10047] that substrate-level acylation of Lys-56 is an obligatory step in the catalysis by PLA2.
对牛胰磷脂酶A2(在大肠杆菌中过量表达的PLA2)进行的定点诱变研究表明,用中性或疏水氨基酸残基取代表面残基Lys-56会导致该酶功能发生意外且显著的变化。对于K56M、K56I和K56F,磷脂酰胆碱微团的kcat增加3至4倍,对于K56N和K56T约增加2倍,但对于K56R则不变。这些结果表明,残基56的侧链对PLA2的活性有显著影响。为了探究活性增强的结构基础,通过X射线晶体学测定了野生型和K56M PLA2的晶体结构,分辨率达到1.8 Å。结果表明,该突变不仅局部扰乱了Met-56侧链的构象,还导致相邻环(残基60 - 70)的构象变化,从而由Met-56、Tyr-52和Tyr-69残基形成了一个疏水口袋。根据眼镜蛇毒PLA2 - 磷脂酰乙醇胺抑制剂类似物复合物的结构[White, S.P., Scott, D. L., Otwinowski, Z., Gleb, M. H., & Sigler, P. (1990) Science 250, 1560 - 1563],将磷脂酰胆碱抑制剂类似物对接至K56M的活性位点,结果显示胆碱部分[N(CH3)3]+能够以高度的表面互补性轻松容纳到新形成的疏水口袋中。这表明残基56与磷脂的头部基团之间可能存在相互作用,解释了当带正电荷的Lys-56被非极性残基(即K56M、K56I和K56F)取代时观察到的活性增强现象。对这一解释的进一步支持来自于带有负电荷侧链的突变体K56E的kcat增加了5倍,其中Glu-56的侧链与带正电荷的胆碱部分之间会存在有吸引力的静电相互作用。我们的结果也反驳了最近的一份报告[Tomasselli, A. G., Hui, J., Fisher, J., Zürcher-Neely, H., Reardon, I.M., Oriaku, E., Kézdy, F.J., & Heinrikson, R.L. (1989) J. Biol. Chem. 264, 10041 - 10047],即Lys-56的底物水平酰化是PLA2催化过程中的一个必要步骤。